×

Arrowhead CEO: We feel great about the drug

6:00 PM ET Mon, 10 Nov 2014

Arrowhead Research's stock took a dive after news about its Hepatitis B drug disappointed, but CEO Chris Anzlone tells CNBC's Meg Tirrell why he is still optimistic.